Patents by Inventor Garth E. RINGHEIM

Garth E. RINGHEIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING VITILIGO USING PD-1 BINDING ANTIBODIES
    Publication number: 20210163595
    Abstract: Provided herein are methods for managing, treating, or preventing vitiligo using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: July 15, 2020
    Publication date: June 3, 2021
    Inventor: Garth E. Ringheim
  • METHODS OF TREATING IMMUNE DISORDERS USING PD-1 BINDING PROTEINS
    Publication number: 20210069325
    Abstract: Provided herein are methods for managing, treating, or preventing immune disorders, such as autoimmune diseases, using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: July 31, 2020
    Publication date: March 11, 2021
    Inventors: Henry H. Chan, Eun Mi Hur, Roli Khattri, Monica Leung, Garth E. Ringheim, Peter H. Schafer
  • Methods of treating vitiligo using PD-1 binding antibodies
    Patent number: 10766958
    Abstract: Provided herein are methods for managing, treating, or preventing vitiligo using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: September 8, 2020
    Assignee: Celgene Corporation
    Inventor: Garth E. Ringheim
  • Methods of treating psoriasis using PD-1 binding antibodies
    Patent number: 10751414
    Abstract: Provided herein are methods for managing, treating, or preventing immune disorders, such as autoimmune diseases, using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: August 25, 2020
    Assignee: Celgene Corporation
    Inventors: Henry H. Chan, Eun Mi Hur, Roli Khattri, Monica Leung, Garth E. Ringheim, Peter H. Schafer
  • METHODS OF TREATING VITILIGO USING PD-1 BINDING PROTEINS
    Publication number: 20180094057
    Abstract: Provided herein are methods for managing, treating, or preventing vitiligo using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: September 18, 2017
    Publication date: April 5, 2018
    Inventor: Garth E. RINGHEIM
  • METHODS OF TREATING IMMUNE DISORDERS USING PD-1 BINDING PROTEINS
    Publication number: 20180092975
    Abstract: Provided herein are methods for managing, treating, or preventing immune disorders, such as autoimmune diseases, using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: September 18, 2017
    Publication date: April 5, 2018
    Inventors: Henry H. CHAN, Eun Mi HUR, Roli KHATTRI, Monica LEUNG, Garth E. RINGHEIM, Peter H. SCHAFER